Chemotherapy induced amenorrhoea in a randomised trial of adjuvant chemotherapy duration in breast cancer
Authors:
- Mark N. LevineMLMark N. Levine
- Peter SkingleyPSPeter Skingley
- Andrew ArnoldAAAndrew Arnold
- H. Abu ZahraHZH. Abu Zahra
- 1 January 1993
- journal article
- clinical trial
- Published by Elsevier in European Journal of Cancer
- Vol. 29 (1) , 21-23
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapyThe Lancet, 1992
- Adjuvant cyclophosphamide, methotrexate, and fluorouracil in patients with axillary node-positive breast cancer: an update of the Guy's/Manchester trial.Journal of Clinical Oncology, 1990
- A randomized trial comparing 12 weeks versus 36 weeks of adjuvant chemotherapy in stage II breast cancer.Journal of Clinical Oncology, 1990
- The magnitude of endocrine effects of adjuvant chemotherapy for premenopausal breast cancer patientsAnnals of Oncology, 1990
- Late effects of adjuvant oophorectomy and chemotherapy upon premenopausal breast cancer patientsAnnals of Oncology, 1990
- Quality of life in stage II breast cancer: an instrument for clinical trials.Journal of Clinical Oncology, 1988
- Evidence of a castration-mediated effect of adjuvant cytotoxic chemotherapy in premenopausal breast cancer.Journal of Clinical Oncology, 1987
- Ten-year experience with CMF-based adjuvant chemotherapy in resectable breast cancerBreast Cancer Research and Treatment, 1985